A lack of well-controlled trials may be attributed to the difficulty in collecting patients with parasitosis, as this is not a common disorder. Pimozide for the treatment of delusional parasitosis is based primarily on data from case series/reports that demonstrate some efficacy in the majority of patients. The use of the drug is limited by its side-effect profile.